A study analyzing 134,444 participants from BRFSS and NHIS reveals that 21.5% and 17.1% respectively suffer from long-COVID, with higher risks in middle-aged, female, Hispanic individuals, those with less education, and residents of certain areas.
The FDA needs to embrace phage therapy to help fight antimicrobial resistance
My daughter, Mallory, died in 2017 at the age of 25 from a multiply resistant bacterial lung infection that followed a double-lung transplant necessitated by
June 23, 2024